Elena Matsa

发表

Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.

Joseph C. Wu, Joseph C Wu, Elena Matsa, 2016, Physiological reviews.

Current status of drug screening and disease modelling in human pluripotent stem cells

Divya Rajamohan, Chris Denning, A. Patel, 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.

George , Vinoj and Denning , Chris ( 2013 ) Current status of drug screening and disease modelling in human pluripotent stem cells

A. Patel, C. Denning, D. Rajamohan, 2016 .

Chemically defined generation of human cardiomyocytes

Praveen Shukla, Bianxiao Cui, Oscar J Abilez, 2014, Nature Methods.

Chemically Defined and Small Molecule-Based Generation of Human Cardiomyocytes

B. Cui, P. Burridge, O. Abilez, 2014, Nature methods.

Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy.

Donald M Bers, Adam J Engler, Jaecheol Lee, 2015, Cell stem cell.

Cardiac Stem Cell Biology: Glimpse of the Past, Present, and Future

Joseph C. Wu, K. Sallam, E. Matsa, 2014, Circulation research.

Faster generation of hiPSCs by coupling high-titer lentivirus and column-based positive selection

C. Denning, L. Young, E. Matsa, 2011, Nature Protocols.

Developing a model system to investigate the epigenetic mechanisms underlying pluripotency in human cells

E. Matsa, Elena Matsa, 2010 .

Human Stem Cells for Modeling Heart Disease and for Drug Discovery

Paul W. Burridge, P. Burridge, Joseph C. Wu, 2014, Science Translational Medicine.

Two new protocols to enhance the production and isolation of human induced pluripotent stem cell lines.

Hanns Lochmüller, R. Kumari, C. Denning, 2011, Stem cell research.

Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity

Russ B Altman, Daniel Bernstein, Yong Fuga Li, 2016, Nature Medicine.

Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes as an In Vitro Model for Coxsackievirus B3–Induced Myocarditis and Antiviral Drug Screening Platform

K. Red-Horse, J. Carette, Sean M. Wu, 2014, Circulation research.

Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation

Divya Rajamohan, Chris Denning, Ian Mellor, 2011, European heart journal.

A Comprehensive TALEN-Based Knockout Library for Generating Human-Induced Pluripotent Stem Cell–Based Models for Cardiovascular Diseases

A. Hendel, M. Porteus, I. Karakikes, 2017, Circulation research.

High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells

Praveen Shukla, Juan C. del Álamo, Wesley L. McKeithan, 2017, Science Translational Medicine.

Induced pluripotent stem cells: at the heart of cardiovascular precision medicine

I. Y. Chen, Joseph C. Wu, Elena Matsa, 2016, Nature Reviews Cardiology.

In Vitro Uses of Human Pluripotent Stem Cell-Derived Cardiomyocytes

C. Denning, E. Matsa, Elena Matsa, 2012, Journal of Cardiovascular Translational Research.

5-hydroxymethyl-cytosine enrichment of non-committed cells is not a universal feature of vertebrate development

Andrew D. Johnson, A. Ruzov, M. Gering, 2012, Epigenetics.

Cardiomyopathy 2 Studying Broken Hearts in a Dish

Joseph C. Wu, K. Sallam, E. Matsa, 2019 .

Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes

K. Morgan, C. Medway, Orestis Georgiou, 2013, European heart journal.

Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro.

Michael P Snyder, Praveen Shukla, Nazish Sayed, 2016, Cell stem cell.

Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling

Yan Zhuge, Ellen Kuhl, Praveen Shukla, 2018, Stem cells.

Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes.

H. R. Lu, R. Passier, C. Mummery, 2013, Stem Cell Research.

Aberrant α-Adrenergic Hypertrophic Response in Cardiomyocytes from Human Induced Pluripotent Cells

Chris Denning, Michael D. Schneider, Tamás Arányi, 2014, Stem cell reports.

INSPIRE: A European training network to Foster research and training in cardiovascular safety pharmacology.

R. Heeren, C. Grandmont, P. Guns, 2020, Journal of pharmacological and toxicological methods.

Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model to Study Trypanosoma cruzi Infection

R. Corrêa-Oliveira, Joseph C. Wu, D. Stevens, 2019, Stem cell reports.

Modeling Cardiovascular Diseases with Patient-Specific Human Pluripotent Stem Cell-Derived Cardiomyocytes.

P. Burridge, Joseph C. Wu, Haodi Wu, 2016, Methods in molecular biology.

Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro.

Kun‐Hsing Yu, M. Snyder, I. Karakikes, 2016, Cell Stem Cell.

Accurate nanoelectrode recording of human pluripotent stem cell-derived cardiomyocytes for assaying drugs and modeling disease

Allister F. McGuire, Bianxiao Cui, Paul W. Burridge, 2017, Microsystems & Nanoengineering.